Publication Information

{'id': 'https://openalex.org/W2034867374', 'doi': 'https://doi.org/10.1034/j.1600-0420.1998.760618.x', 'title': 'A comparison of the efficacy and tolerability of dorzolamide and acetazolamide as adjunctive therapy to timolol', 'display_name': 'A comparison of the efficacy and tolerability of dorzolamide and acetazolamide as adjunctive therapy to timolol', 'publication_year': 1998, 'publication_date': '1998-12-01', 'ids': {'openalex': 'https://openalex.org/W2034867374', 'doi': 'https://doi.org/10.1034/j.1600-0420.1998.760618.x', 'mag': '2034867374', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/9881560'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1034/j.1600-0420.1998.760618.x', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1034/j.1600-0420.1998.760618.x', 'source': {'id': 'https://openalex.org/S195714098', 'display_name': 'Acta Ophthalmologica Scandinavica', 'issn_l': '1395-3907', 'issn': ['1395-3907', '1600-0420'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1034/j.1600-0420.1998.760618.x', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5007067019', 'display_name': 'Jill Hutzelmann', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I192545095', 'display_name': 'United States Military Academy', 'ror': 'https://ror.org/01jepya76', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I1304082316', 'https://openalex.org/I1330347796', 'https://openalex.org/I192545095', 'https://openalex.org/I4210088792']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jill E. Hutzelmann', 'raw_affiliation_strings': ['Merck Research Laboratories, West Point, PA'], 'affiliations': [{'raw_affiliation_string': 'Merck Research Laboratories, West Point, PA', 'institution_ids': ['https://openalex.org/I192545095']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110017584', 'display_name': 'Adam B. Polis', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I192545095', 'display_name': 'United States Military Academy', 'ror': 'https://ror.org/01jepya76', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I1304082316', 'https://openalex.org/I1330347796', 'https://openalex.org/I192545095', 'https://openalex.org/I4210088792']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Adam B. Polis', 'raw_affiliation_strings': ['Merck Research Laboratories, West Point, PA'], 'affiliations': [{'raw_affiliation_string': 'Merck Research Laboratories, West Point, PA', 'institution_ids': ['https://openalex.org/I192545095']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5061955018', 'display_name': 'Andrew J. Michael', 'orcid': 'https://orcid.org/0000-0002-2403-5019'}, 'institutions': [{'id': 'https://openalex.org/I4210138378', 'display_name': 'Dominion (United States)', 'ror': 'https://ror.org/038q98v71', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210138378']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Andrew J. Michael', 'raw_affiliation_strings': ['Dominion Eye Associates, Richmond, VA'], 'affiliations': [{'raw_affiliation_string': 'Dominion Eye Associates, Richmond, VA', 'institution_ids': ['https://openalex.org/I4210138378']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5051647158', 'display_name': 'Ingrid Adamsons', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I192545095', 'display_name': 'United States Military Academy', 'ror': 'https://ror.org/01jepya76', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I1304082316', 'https://openalex.org/I1330347796', 'https://openalex.org/I192545095', 'https://openalex.org/I4210088792']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Ingrid A. Adamsons', 'raw_affiliation_strings': ['Merck Research Laboratories, West Point, PA'], 'affiliations': [{'raw_affiliation_string': 'Merck Research Laboratories, West Point, PA', 'institution_ids': ['https://openalex.org/I192545095']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5109146868', 'display_name': 'The Oral to Topical CAI Study Group', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'The Oral to Topical CAI Study Group', 'raw_affiliation_strings': ['listed in acknowledgments'], 'affiliations': [{'raw_affiliation_string': 'listed in acknowledgments', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 2.648, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 30, 'citation_normalized_percentile': {'value': 0.797569, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 88, 'max': 89}, 'biblio': {'volume': '76', 'issue': '6', 'first_page': '717', 'last_page': '722'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10250', 'display_name': 'Glaucoma and retinal disorders', 'score': 0.9956, 'subfield': {'id': 'https://openalex.org/subfields/2731', 'display_name': 'Ophthalmology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10250', 'display_name': 'Glaucoma and retinal disorders', 'score': 0.9956, 'subfield': {'id': 'https://openalex.org/subfields/2731', 'display_name': 'Ophthalmology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11826', 'display_name': 'Ocular Infections and Treatments', 'score': 0.9779, 'subfield': {'id': 'https://openalex.org/subfields/2731', 'display_name': 'Ophthalmology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10997', 'display_name': 'Ocular Surface and Contact Lens', 'score': 0.9604, 'subfield': {'id': 'https://openalex.org/subfields/2739', 'display_name': 'Public Health, Environmental and Occupational Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/tolerability', 'display_name': 'Tolerability', 'score': 0.5669092}, {'id': 'https://openalex.org/keywords/acetazolamide', 'display_name': 'Acetazolamide', 'score': 0.5047685}, {'id': 'https://openalex.org/keywords/dorzolamide', 'display_name': 'Dorzolamide', 'score': 0.48765385}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.6717499}, {'id': 'https://openalex.org/C2778375690', 'wikidata': 'https://www.wikidata.org/wiki/Q7814214', 'display_name': 'Tolerability', 'level': 3, 'score': 0.5669092}, {'id': 'https://openalex.org/C2777405951', 'wikidata': 'https://www.wikidata.org/wiki/Q413690', 'display_name': 'Acetazolamide', 'level': 2, 'score': 0.5047685}, {'id': 'https://openalex.org/C2776727336', 'wikidata': 'https://www.wikidata.org/wiki/Q415401', 'display_name': 'Dorzolamide', 'level': 4, 'score': 0.48765385}, {'id': 'https://openalex.org/C118487528', 'wikidata': 'https://www.wikidata.org/wiki/Q161437', 'display_name': 'Ophthalmology', 'level': 1, 'score': 0.4422869}, {'id': 'https://openalex.org/C2778073030', 'wikidata': 'https://www.wikidata.org/wiki/Q413994', 'display_name': 'Timolol', 'level': 3, 'score': 0.39631456}, {'id': 'https://openalex.org/C161191863', 'wikidata': 'https://www.wikidata.org/wiki/Q199655', 'display_name': 'Library science', 'level': 1, 'score': 0.33447313}, {'id': 'https://openalex.org/C204787440', 'wikidata': 'https://www.wikidata.org/wiki/Q188504', 'display_name': 'Alternative medicine', 'level': 2, 'score': 0.14631593}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.1295777}, {'id': 'https://openalex.org/C2781092963', 'wikidata': 'https://www.wikidata.org/wiki/Q650050', 'display_name': 'Intraocular pressure', 'level': 2, 'score': 0.094907135}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.07509008}, {'id': 'https://openalex.org/C41008148', 'wikidata': 'https://www.wikidata.org/wiki/Q21198', 'display_name': 'Computer science', 'level': 0, 'score': 0.0749512}], 'mesh': [{'descriptor_ui': 'D000086', 'descriptor_name': 'Acetazolamide', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000319', 'descriptor_name': 'Adrenergic beta-Antagonists', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D002257', 'descriptor_name': 'Carbonic Anhydrase Inhibitors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D005902', 'descriptor_name': 'Glaucoma, Open-Angle', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D009798', 'descriptor_name': 'Ocular Hypertension', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D013876', 'descriptor_name': 'Thiophenes', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D013999', 'descriptor_name': 'Timolol', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000086', 'descriptor_name': 'Acetazolamide', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000086', 'descriptor_name': 'Acetazolamide', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D000086', 'descriptor_name': 'Acetazolamide', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D000284', 'descriptor_name': 'Administration, Oral', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000287', 'descriptor_name': 'Administration, Topical', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000319', 'descriptor_name': 'Adrenergic beta-Antagonists', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D000319', 'descriptor_name': 'Adrenergic beta-Antagonists', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000319', 'descriptor_name': 'Adrenergic beta-Antagonists', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000369', 'descriptor_name': 'Aged, 80 and over', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002257', 'descriptor_name': 'Carbonic Anhydrase Inhibitors', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D002257', 'descriptor_name': 'Carbonic Anhydrase Inhibitors', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D002257', 'descriptor_name': 'Carbonic Anhydrase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017024', 'descriptor_name': 'Chemotherapy, Adjuvant', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004311', 'descriptor_name': 'Double-Blind Method', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005902', 'descriptor_name': 'Glaucoma, Open-Angle', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007429', 'descriptor_name': 'Intraocular Pressure', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D007429', 'descriptor_name': 'Intraocular Pressure', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009798', 'descriptor_name': 'Ocular Hypertension', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009883', 'descriptor_name': 'Ophthalmic Solutions', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D009883', 'descriptor_name': 'Ophthalmic Solutions', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D009883', 'descriptor_name': 'Ophthalmic Solutions', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D009883', 'descriptor_name': 'Ophthalmic Solutions', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012449', 'descriptor_name': 'Safety', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013876', 'descriptor_name': 'Thiophenes', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013876', 'descriptor_name': 'Thiophenes', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D013876', 'descriptor_name': 'Thiophenes', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D013999', 'descriptor_name': 'Timolol', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013999', 'descriptor_name': 'Timolol', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D013999', 'descriptor_name': 'Timolol', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1034/j.1600-0420.1998.760618.x', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1034/j.1600-0420.1998.760618.x', 'source': {'id': 'https://openalex.org/S195714098', 'display_name': 'Acta Ophthalmologica Scandinavica', 'issn_l': '1395-3907', 'issn': ['1395-3907', '1600-0420'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/9881560', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1034/j.1600-0420.1998.760618.x', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1034/j.1600-0420.1998.760618.x', 'source': {'id': 'https://openalex.org/S195714098', 'display_name': 'Acta Ophthalmologica Scandinavica', 'issn_l': '1395-3907', 'issn': ['1395-3907', '1600-0420'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4235158511', 'https://openalex.org/W2405215622', 'https://openalex.org/W2099196025', 'https://openalex.org/W2097616776', 'https://openalex.org/W2094530856', 'https://openalex.org/W2062326061', 'https://openalex.org/W2028321409', 'https://openalex.org/W2016817093', 'https://openalex.org/W2006618734', 'https://openalex.org/W1967566161'], 'abstract_inverted_index': {'To': [0], 'compare': [1], 'the': [2, 61, 74, 88, 112, 122, 141, 151], 'efficacy': [3], 'and': [4, 12, 102, 108, 115, 118, 131, 137, 144, 147], 'tolerability': [5], 'of': [6, 56], 'dorzolamide': [7, 25, 62, 89, 113, 142, 165], 'to': [8, 24, 30, 40, 79], 'acetazolamide.Following': [9], 'a': [10], 'timolol': [11], 'acetazolamide': [13, 37, 75, 123, 152], 'run-in,': [14], '105': [15], 'patients': [16, 35, 45], 'with': [17, 162], 'elevated': [18], 'intraocular': [19], 'pressure': [20], '(IOP)': [21], 'were': [22, 105, 134], 'randomized': [23], 'or': [26], 'acetazolamide,': [27, 163], 'in': [28, 87], 'addition': [29], 'timolol,': [31], 'for': [32, 60, 73, 111, 121, 140, 150], '12': [33, 104, 133], 'weeks.More': [34], 'receiving': [36, 46], 'discontinued': [38], 'due': [39], 'clinical': [41], 'adverse': [42, 58], 'experiences': [43, 59], 'than': [44], 'dorzolamide;': [47], '13': [48], '(25%)': [49], 'vs.': [50, 92], '1': [51, 101, 160], '(2%);': [52], 'p<0.001.': [53, 81], 'The': [54, 95, 125], 'prevalence': [55], 'systemic': [57], 'group': [63, 90], 'dropped': [64], 'by': [65, 67], '50%': [66], 'Week': [68, 103, 132], '12,': [69], 'but': [70], 'remained': [71], 'unchanged': [72], 'group,': [76, 114, 143], 'as': [77], 'compared': [78], 'baseline;': [80], 'Ocular': [82], 'burning/stinging': [83], 'was': [84, 155], 'more': [85], 'common': [86], '(21%': [91], '0%;': [93], 'p<0.001).': [94], 'mean': [96, 126], 'trough': [97], 'IOP': [98, 128, 154], 'at': [99, 129], 'Day': [100], '20.5': [106, 119], 'mmHg': [107, 110, 117, 120, 136, 139, 146, 149], '21.8': [109], '20.4': [116], 'group.': [124], 'peak': [127], 'Dayl': [130], '18.9': [135], '20.0': [138], '18.7': [145], '18.6': [148], 'group.Mean': [153], 'slightly': [156], 'lower': [157], '(by': [158], 'approximately': [159], 'mmHg)': [161], 'while': [164], 'demonstrated': [166], 'much': [167], 'better': [168], 'tolerability.': [169]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2034867374', 'counts_by_year': [{'year': 2023, 'cited_by_count': 3}, {'year': 2022, 'cited_by_count': 2}, {'year': 2021, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 1}, {'year': 2016, 'cited_by_count': 1}, {'year': 2015, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 1}, {'year': 2013, 'cited_by_count': 1}], 'updated_date': '2025-01-06T01:42:50.631969', 'created_date': '2016-06-24'}